This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The FDA warning highlights ongoing anxiety over quality control among pharmaceut...
This week in health care business news: Rising costs hit health insurers, United...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Public health experts worry the FDA workforce will be slashed, impeding the abil...
Morning. Today, we have a look at the White House's reported plans to make major...
Get your daily dose of health and medicine every weekday with STAT’s free newsle...
The life sciences industry must step up to reduce the gap between health care sp...
The public misunderstands antibiotic-resistant infections — and so does the FDA.
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedi...
Amid a shakeup in U.S. science, researchers are expressing alarm over the integr...
Documents analyzed by STAT show that big losers under the NIH's cuts to biomedic...
The Howard Hughes Medical Institute abruptly ended a $60 million program to impr...
Elected leaders in Massachusetts said the NIH policy change will interrupt cruci...
National Institutes of Health slashed overhead costs allowed under its grants to...
After two decades of work in biomedical research policy, there is no topic Carri...
The drastic reduction in indirect costs is not a path to innovation or cost savi...
The NIH said Friday night that it would slash support for indirect costs on all ...
Applications for a prestigious NIH grant that supports Ph.D. students from margi...
The Trump administration on Friday said global malaria aid can restart, but it w...
Republicans are looking for ways to pay for the cost of extending the tax cuts, ...
From new hires to departures, promotions and transfers, here are the latest comi...
The FDA is always trying to staff up, and already struggles to fulfill some duties.
Morning. Today, we have a look at the White House's reported plans to make major...
Lawmakers want the FDA to review whether a Super Bowl ad from Hims & Hers runs a...